Compare · AGL vs MGRX
AGL vs MGRX
Side-by-side comparison of agilon health inc. (AGL) and Mangoceuticals Inc. (MGRX): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both AGL and MGRX operate in Misc Health and Biotechnology Services (Health Care), so they compete in similar markets.
- AGL is the larger of the two at $1.49B, about 208.2x MGRX ($7.1M).
- MGRX has been more active in the news (8 items in the past 4 weeks vs 3 for AGL).
- AGL has more recent analyst coverage (25 ratings vs 0 for MGRX).
- Company
- agilon health inc.
- Mangoceuticals Inc.
- Price
- -
- -
- Market cap
- $1.49B
- $7.1M
- 1M return
- -4.66%
- -
- 1Y return
- +257.58%
- -
- Industry
- Misc Health and Biotechnology Services
- Misc Health and Biotechnology Services
- Exchange
- NYSE
- NASDAQ
- IPO
- 2021
- 2023
- News (4w)
- 3
- 8
- Recent ratings
- 25
- 0
AGL
agilon health inc.
agilon health, inc. offers healthcare services for seniors through primary care physicians in the communities of the United States. The company was formerly known as Agilon Health Topco, Inc. and changed its name to agilon health, inc. in March 2021. The company was founded in 2016 and is based in Long Beach, California.
Latest AGL
- agilon health Sets Date to Report Third Quarter 2026 Financial Results
- agilon health and The Jackson Clinic Advance Their Partnership Through Senior Health Connect ACO
- agilon health and Springfield Clinic Broaden Partnership Through Senior Health Connect ACO
- agilon health upgraded by Bernstein with a new price target
- agilon health and Family Practice Center Expand Relationship Through Senior Health Connect ACO
- agilon health Announces Revised Presentation Time at the 2026 Jefferies Healthcare Services and Technology Conference
- agilon health to Participate in Upcoming Conferences
- Chief Accounting Officer Gertsch Timothy covered exercise/tax liability with 17 shares, decreasing direct ownership by 0.12% to 14,152 units (SEC Form 4) (withholding tax)
- Amendment: SEC Form SCHEDULE 13G/A filed by agilon health inc.
- Amendment: SEC Form SCHEDULE 13G/A filed by agilon health inc.
Latest MGRX
- SEC Form 8-K filed by Mangoceuticals Inc.
- SEC Form 424B5 filed by Mangoceuticals Inc.
- Mangoceuticals Closes Registered Direct Offering Priced at 74% Premium to Recent Market Close
- SEC Form 4 filed by Mangoceuticals Inc.
- SEC Form 4 filed by Mangoceuticals Inc.
- SEC Form 4 filed by Mangoceuticals Inc.
- Amendment: SEC Form SCHEDULE 13D/A filed by Mangoceuticals Inc.
- Mangoceuticals Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Financial Statements and Exhibits, Unregistered Sales of Equity Securities, Regulation FD Disclosure
- Mangoceuticals Inc. filed SEC Form 8-K: Termination of a Material Definitive Agreement, Financial Statements and Exhibits
- SEC Form 10-Q filed by Mangoceuticals Inc.